№ lp_1_2_17022
File format: docx
Character count: 41157
File size: 438 KB
This guideline provides a structured approach for shared care prescribing for complex ADHD treatment in adults, outlining roles and responsibilities of both specialists and GPs, and includes monitoring requirements for medications such as methylphenidate and atomoxetine.
Year:
2023
Region / City:
South East London
Topic:
Complex ADHD treatment in adults
Document Type:
Guideline
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Healthcare professionals, specialists, GPs
Validity Period:
Indefinite
Approval Date:
Not specified
Revision Date:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
Humber and North Yorkshire
Theme:
Medicine prescribing, healthcare guidelines
Document Type:
Guideline, formulary
Organization / Institution:
Humber and North Yorkshire Area Prescribing Committee
Author:
Humber and North Yorkshire Area Prescribing Committee
Target Audience:
Healthcare professionals (pharmacists, doctors, primary and secondary care providers)
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Document type:
Clinical guideline
Organisation:
Australian Medical Assistance Team (AUSMAT)
Context:
Emergency Medical Team (EMT) Type 1 and 2 field hospitals and specialist cells
Jurisdiction:
Australia
Regulatory basis:
Australian legislation
Scope:
Prescribing, dispensing and administration of medicines
Target personnel:
Medical officers, pharmacists, nurses, midwives, paramedics
Medicine charts:
National Inpatient Medication Chart (NIMC), Patient Treatment Card
Restricted medicines:
Schedule 8 (S8), Schedule 4R (S4R)
IV administration guidance:
Gravity infusion and limited pump use
Reference standards:
WHO Classification and Minimum Standards for Emergency Medical Teams
Document owner:
Medical Director
Date last reviewed:
March 2023
Next review date:
March 2025
Supporting resources:
Australian Injectable Drugs Handbook; Paediatric Injectable Guidelines
Year:
2021
Region / city:
West Yorkshire
Theme:
Asthma Management
Document type:
Guideline
Organization:
British Thoracic Society, National Institute for Health and Care Excellence (NICE), Global Initiative for Asthma (GINA)
Author:
Not specified
Target audience:
Healthcare professionals
Effective period:
Ongoing
Approval date:
Not specified
Revision date:
Not specified
Year:
2019–2020
Country:
England
Thematic area:
Opioid prescribing and medicines safety
Document type:
Technical specification
Related programme:
Prescribed Medicines Review
Issuing bodies:
NHS Business Services Authority; Wessex Academic Health Science Network
Contributing organisations:
Public Health England; Medicines and Healthcare products Regulatory Agency
Intended audience:
Healthcare professionals; NHS organisations
Data sources:
NHS prescribing data; Electronic Prescribing System
Medicine classifications used:
British National Formulary
Appendices included:
Medicine classes; Oral Morphine Equivalent values; Working groups
Year:
2023
Region / City:
United Kingdom
Topic:
Non-Medical Prescribing Application
Document Type:
Application Form
Institution:
Various UK Universities
Author:
North West Universities NMP Collaboration
Target Audience:
Healthcare professionals applying for non-medical prescribing courses
Duration:
Ongoing
Approval Date:
N/A
Date of Changes:
N/A
Note:
Year
Topic:
Independent Prescribing
Document Type:
Information for healthcare professionals
Organization / Institution:
University of Leeds
Target Audience:
Pharmacists seeking to undertake Independent Prescribing course
Context:
A guide for prospective Designated Prescribing Practitioners, explaining the requirements and responsibilities for supervising trainee non-medical prescribers in the Independent Prescribing course at the University of Leeds.
Year:
2023
Region / city:
Lancashire and South Cumbria
Topic:
Medicines management and preparation for CQC inspection
Document type:
Guideline
Organisation:
PrescQIPP
Author:
PrescQIPP Medicines Optimisation Team
Target audience:
GP practices, PCN staff members
Date of approval:
Not specified
Date of changes:
Not specified
Year:
2023
Region / city:
South East London
Topic:
Shared care prescribing for narcolepsy and idiopathic hypersomnia treatment
Document type:
Medical guideline
Organization / institution:
South East London Interface Prescribing Policy
Author:
Specialist clinicians, GP teams
Target audience:
Healthcare professionals, GPs, specialists
Period of validity:
Ongoing until updated
Approval date:
Not specified
Date of amendments:
Not specified
Year:
2022
Region / City:
South East London
Topic:
Shared care prescribing for ADHD treatment in pediatrics
Document Type:
Guideline
Organization / Institution:
South East London Health Authority
Author:
Specialist Clinical Team
Target Audience:
General Practitioners (GPs), Pediatricians
Period of Validity:
Ongoing
Approval Date:
2022
Date of Amendments:
September 2022
Document type:
Factsheet
Issuing body:
Office of the Chief Psychiatrist
Legislation referenced:
Mental Health and Wellbeing Act 2022
Subject:
Chemical restraint
Regulatory context:
Restrictive interventions
Intended audience:
Prescribing clinicians
Scope:
Mental health and wellbeing services
Jurisdiction:
Public mental health system
Related documents:
Chief Psychiatrist’s guideline for restrictive interventions; reporting directive for restrictive interventions
Focus:
Determination and reporting requirements
Year:
2026
Region / City:
United Kingdom
Topic:
Non-Medical Prescribing Course Application
Document Type:
Application Form
Organization / Institution:
North West Universities NMP Collaboration
Author:
Not specified
Target Audience:
Healthcare professionals seeking non-medical prescribing qualifications
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Modifications:
Not specified
Year:
2025
Region / City:
Massachusetts
Topic:
Healthcare, Provider Enrollment
Document Type:
FAQ
Organization:
MassHealth
Author:
MassHealth
Target Audience:
Healthcare providers, billing providers, authorized ORP providers
Effective Period:
Ongoing
Approval Date:
July 23, 2025
Modification Date:
Not specified
Year:
2023
Region / City:
Victoria
Subject:
Medication Safety, High-Risk Medicines
Document Type:
Guidance
Organization:
Victorian Department of Health
Author:
eHealth High Risk Medicine Safety Advisory Group
Target Audience:
Healthcare professionals, Clinical staff
Period of validity:
Ongoing
Approval Date:
2023
Date of Changes:
None
Version number:
6.0
Approved by:
Medicines Committee
Ratified by:
Medicines Committee
Date ratified:
June 2023
Original author:
Luton & Bedfordshire Lead Pharmacist
Executive Director lead:
Chief Medical Officer
Implementation Date:
July 2023
Last Review Date:
June 2023
Next Review Date:
June 2026
Services:
Trustwide, Mental Health and LD, Community Health Services
Type of document:
Policy
Scope:
Long-acting antipsychotic injections, typical and atypical
Target audience:
Clinicians, pharmacists, mental health services staff
Document structure:
Includes guidance on initiation, choice, and monitoring of depot injections, adverse effect reporting, and appendices with forms and rating scales
Year:
2023
Region / City:
Humber and North Yorkshire
Topic:
Shared Care Protocols, Prescribing of Medication
Document Type:
Guide
Organization:
Humber and North Yorkshire Integrated Care Partnership
Author:
Not specified
Target Audience:
Healthcare professionals (specialists, general practitioners, primary care providers)
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2017
Region / City:
United States
Subject:
Workforce Development, Monitoring
Document Type:
Guideline
Agency/Organization:
U.S. Department of Education, U.S. Department of Labor, U.S. Department of Health and Human Services
Author:
Multiple Federal Agencies
Target Audience:
State and local workforce development boards, federal partners
Period of Validity:
2017–ongoing
Approval Date:
November 9, 2017
Date of Amendments:
Not specified
Year:
2026
Version:
NENC v2.0
Date published:
22 January 2026
Planned review date:
October 2027
Region:
North East and North Cumbria
Healthcare system:
NHS
Clinical area:
Neurology
Condition:
Amyotrophic lateral sclerosis
Medicine:
Riluzole
Document type:
Shared care protocol
Indication:
Extension of survival or time to mechanical ventilation in ALS
Target population:
Adults
Intended audience:
NHS healthcare professionals
Initiating authority:
Neurological specialist services
Regulatory reference:
NICE Technology Appraisal TA20
Prescribing setting:
Secondary to primary care transfer
Monitoring requirements:
Liver function tests, full blood count, urea and electrolytes
Route of administration:
Oral or enteral
Licensing status:
Licensed for ALS only
Year:
2026
Region / City:
United States
Topic:
Healthcare, Medicare, Accountable Care Organizations
Document Type:
Instruction Manual
Organization:
Centers for Medicare & Medicaid Services (CMS)
Author:
CMS
Target Audience:
Accountable Care Organizations (ACOs), Healthcare Administrators, CMS Staff
Effective Period:
Ongoing, as of January 2026
Approval Date:
January 2026
Revision History Date:
January 2026
Version:
1.0.4
Note:
Region / City
Topic:
Software Installation
Document Type:
Revision History
Organization / Institution:
IVI Foundation
Target Audience:
Developers, System Administrators